Lawrence Green, MD: Optimizing Care With Flexible Dosing for Patients With Severe Acne

Lawrence Green, MD, a board-certified dermatologist and clinical professor of dermatology at George Washington University School of Medicine, discusses the use of Absorica LD for patients with severe nodulocystic acne or whose acne has not responded to topical agents, oral antibiotics, or hormonal therapies. Unlike other isotretinoins that must be taken twice daily with fatty meals, Dr. Green explains that Absorica LD has been shown to be almost equally absorbed with or without food. There are simplified dosing options made possible by multiple dosing strengths, allowing straightforward weight-based regimens that reduce dosing errors.

MORE EXPERT PERSPECTIVES IN ACNE:

Leon Kircik, MD: Maximizing Bioavailability and Patient Outcomes With Oral Acne Therapy

Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York, discusses the history of isotretinoin

Hilary Baldwin, MD: Dosing Options with Micronized Treatment for Acne

Dr. Hilary Baldwin, the director of the Acne Treatment and Research Center in Brooklyn, New York, discusses a low-dose formulation of isotretinoin designed for better

Emmy Graber, MD: Use of Micronized Formulations in Acne Treatment

Dr. Graber explores how micronized formulations can improve drug absorption in acne therapy. She explains how enhanced absorption may support more consistent treatment outcomes and